跳至主要内容
临床试验/EUCTR2011-000644-16-EE
EUCTR2011-000644-16-EE进行中(未招募)不适用

High volume haemodiafiltration in treatment of severe sepsis -- impact on pharmacokinetics of doripenem and piperacillin tazobactam and inflammatory response

niversity of Tartu, Clinic of Anaesthesiology and Intensive Care0 个研究点目标入组 30 人开始时间: 2011年3月24日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • age >= 18 years
  • severe sepsis or septic shock as defined by the ACCP/SCC Consensus Conference
  • acute renal failure requiring renal replacement therapy
  • written informed consent signed by legal representative
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • contraindication for study drug use
  • life expectancy less than 6 h

研究者

发起方
niversity of Tartu, Clinic of Anaesthesiology and Intensive Care

相似试验